Countries North America

MedHQ Partners with Avanza Healthcare Strategies

 MedHQ, a leading provider of technology-enabled expert services including human resources, staffing, and financial management to outpatient healthcar...

 February 10, 2023 | News

U.S. Centers for Disease Control to extend National Wastewater Surveillance System contract with Biobot Analytics

As part of NWSS, Biobot contributes data from more than 400 locations from over 250 counties across a total of 50 states and U.S. Territories, providing co...

 February 09, 2023 | News

Parse Biosciences Announces Evercode TCR and Gene Capture

 Parse Biosciences, a leading provider of accessible and scalable single-cell sequencing solutions, today announced the availability of Evercode&trade...

 February 08, 2023 | News

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...

 February 03, 2023 | News

Magenta Therapeutics to Explore Strategic Alternatives

As part of this review process, Magenta will explore potential strategic alternatives that may include, but are not limited to, an acquisition, merger, bus...

 February 03, 2023 | News

Superstratum and AirAnswers® Team-Up in the Fight Against Sick Building Syndrome

Both companies join forces to identify and alleviate indoor mycotoxins and molds that can contribute to symptoms associated with sick building syndrome. Si...

 February 02, 2023 | News

Amjevita™ (Adalimumab-atto), First Biosimilar to Humira®, Now Available in the United States

Amgen (NASDAQ:AMGN)  announced AMJEVITA™ (adalimumab-atto), a biosimilar to Humira®* (adalimumab), is now available in the Un...

 February 01, 2023 | News

Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05%

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr....

 January 30, 2023 | News

Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a g...

 January 23, 2023 | News

Summit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific Antibody

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that we have completed the c...

 January 23, 2023 | News

Speakers Announced for 2023 BIO CEO & Investor Conference

The Biotechnology Innovation Organization (BIO) will hold its CEO & Investor Conference February 6-9, 2023 to bring biotech companies togethe...

 January 18, 2023 | News

Novotech Acquires US-based Drug Development Consulting Firm, CBR International

Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR International, a global product development, clinical oversi...

 January 12, 2023 | News

Indegene expands Europe presence with new center in Germany to enable life sciences companies be future ready

With this center, Indegene is further strengthening its presence in Europe to help life sciences companies fast-track digital transformation across the c...

 January 11, 2023 | News

Complete Genomics Launches Full Sequencing Platforms at Biotech Showcase™ 2023

Rade Drmanac, PhD, Chief Scientific Officer, announced "free three-month trial" program and "reagent rental leasing" program, giving customers the opportun...

 January 11, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close